Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01727336
Title Study of Dalantercept in Patients With Advanced Renal Cell Carcinoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Acceleron Pharma, Inc.
Indications

renal cell carcinoma

Therapies

Axitinib + Dalantercept

Axitinib

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Arizona Oncology Associates, PC - HOPE Tucson Arizona 85718 United States Details
Highlands Oncology Group, PA Fayetteville Arkansas 72758 United States Details
University of California Irvine Medical Center Irvine California 92697 United States Details
University of California, Los Angeles (UCLA) - Institute of Urologic Oncology Los Angeles California 90095 United States Details
Stanford Hospital and Clinics Stanford California United States Details
Rocky Mountain Cancer Centers Aurora Colorado United States Details
Georgetown University Medical Center Washington District of Columbia United States Details
University of Miami Miami Florida United States Details
H. Lee Moffitt Cancer Center & Research Institute Tampa Florida United States Details
Loyola University Chicago Chicago Illinois United States Details
Indiana University Health Melvin & Bren Simon Cancer Center Indianapolis Indiana United States Details
Beth Israel Deaconess Med Center Boston Massachusetts United States Details
Lahey Hospital & Medical Center Burlington Massachusetts United States Details
Nebraska Methodist Hospital Omaha Nebraska United States Details
Comprehensive Cancer Centers of Nevada Las Vegas Nevada United States Details
Cancer Center Hackensack UMC Hackensack New Jersey United States Details
University of New Mexico Albuquerque New Mexico United States Details
New York Oncology Hematology, P.C. Albany New York United States Details
North Shore LIJ Center for Advance Medicine Lake Success New York United States Details
Mem Sloan Kettering Cancer Center New York New York United States Details
NYU Cancer Institute New York New York United States Details
Levin Cancer Institute Charlotte North Carolina United States Details
Cleveland Clinic Cleveland Ohio United States Details
Northwest Cancer Specialists, P.C. Tualatin Oregon United States Details
Saint Luke's University Health Network Bethlehem Pennsylvania United States Details
Penn State Milton S- Hershey Medical Center Hershey Pennsylvania United States Details
Fox Chase Cancer Center Philadelphia Pennsylvania United States Details
University of Pittsburgh, Hillman Cancer Center Pittsburgh Pennsylvania United States Details
Medical University of South Carolina Charleston South Carolina United States Details
Texas Oncology-South Austin Austin Texas United States Details
Texas Oncology - Baylor Charles A. Sammons Cancer Center Dallas Texas United States Details
Texas Oncology-El Paso Cancer Treatment Center Grandview El Paso Texas United States Details
Texas Oncology - Memorial City Houston Texas United States Details
Texas Oncology - Tyler and Longview Tyler Texas United States Details
Shenandoah Oncology P.C. Winchester Virginia United States Details
University of Wisconsin, Carbone Cancer Center Madison Wisconsin United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field